Cancer cells’ epigenetic composition and predisposition to histone deacetylase inhibitor sensitization
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer cells’ epigenetic composition and predisposition to histone deacetylase inhibitor sensitization
Authors
Keywords
-
Journal
Epigenomics
Volume 3, Issue 2, Pages 145-155
Publisher
Future Medicine Ltd
Online
2011-04-20
DOI
10.2217/epi.11.12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Setting and resetting of epigenetic marks in malignant transformation and development
- (2010) Holger Richly et al. BIOESSAYS
- Targeting the Mitogen-Activated Protein Kinase Pathway: Physiological Feedback and Drug Response
- (2010) C. A. Pratilas et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-α (TNF-α) Expression in Cardiomyocytes during Lipopolysaccharide Stimulation
- (2010) Huaqing Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
- (2010) Kyle M Miller et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
- (2010) J.- H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
- (2010) Sara Siddiqi et al. Current Stem Cell Research & Therapy
- The Biology of Chromatin Remodeling Complexes
- (2009) Cedric R. Clapier et al. Annual Review of Biochemistry
- The multiple facets of histone H4-lysine 20 methylationThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB’s 51st Annual Meeting – Epigenetics and Chromatin Dynamics, and has undergone the Journal’s usual peer review process.
- (2009) Hongbo Yang et al. Biochemistry and Cell Biology
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
- (2009) S. E. Elsheikh et al. CANCER RESEARCH
- Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
- (2009) D. S. Schrump CLINICAL CANCER RESEARCH
- Targeting the RET Pathway in Thyroid Cancer
- (2009) S. A. Wells et al. CLINICAL CANCER RESEARCH
- New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
- (2009) Shundong Cang et al. Journal of Hematology & Oncology
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- Tumor Cell Growth Inhibition and Cell Differentiation Analysis in a Canine Mammary Tumor Cell Line (MCM-B2) Treated with Four Chemical Reagents
- (2009) Manabu WATANABE et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Human DNA methylomes at base resolution show widespread epigenomic differences
- (2009) Ryan Lister et al. NATURE
- Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity
- (2008) Kouichi Miura et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now